发明名称 KINASE INHIBITORS
摘要 Provided herein are kinase inhibiting compounds and methods of using the same.
申请公布号 US2014323464(A1) 申请公布日期 2014.10.30
申请号 US201214118541 申请日期 2012.05.16
申请人 PRINCIPIA BIOPHARMA, INC. ;THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 发明人 Taunton, JR. John William;Brameld Kenneth Albert;Goldstein David Michael;Mcfarland Jesse;Krishnan Shyam;Choy Jonathan
分类号 C07D487/04;C07D471/04;C07D403/12;C07D401/12;C07D401/14;C07D239/48;C07D239/94 主分类号 C07D487/04
代理机构 代理人
主权项 1. A compound of Formula I: wherein R1 is substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; Z is a bond, —O—, —N(Ra)—, —S—, —SO—, —SO2—, substituted or unsubstituted alkylene, substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene or substituted or unsubstituted heteroarylene; Ra is hydrogen or unsubstituted alkyl; L1 is a bond, —C(O)—, —N(L2R5)C(O)—, —OC(O)—, —S(O)n—, —(OL2R5)OP(O)—, —N(L2R5)SO2—, —(N(L2R5))NP(O)—, substituted or unsubstituted alkylene, substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, substituted or unsubstituted heteroarylene,wherein A is substituted or unsubstituted heterocycloalkylene or substituted or unsubstituted heteroarylene; n is 0, 1 or 2; L2 is a bond, substituted or unsubstituted alkylene, substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene; R5 is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R2 and R3 are independently substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl, or R2 and R3 are optionally joined together to form a substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R4 is independently hydrogen, —NR4AR4B, —OR4A, —SR4A, —CN, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and R4A and R4B are independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; or a pharmaceutically acceptable salt thereof.
地址 Menlo Park CA US